REGN

Regeneron

$585.48

-14.52 (-2.42%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 07.10.2025
$722.20
(+23.35%)
Strong Buy: 4
Buy: 15
Hold: 6
Sell: 0
Strong Sell: 1
Description:
Regeneron Pharmaceuticals, Inc. is a leading American biotechnology company based in Westchester County, New York, known for its innovative research and development in the field of monoclonal antibodies and therapeutic proteins. Established initially to explore neurotrophic factors, Regeneron has successfully expanded its focus to include a broad array of therapeutic areas, including oncology, ophthalmology, and immunology, highlighted by its flagship products such as Eylea and Dupixent. The company's robust pipeline and commitment to scientific advancement position it as a key player in the biopharmaceutical industry, with a strong track record of delivering novel therapies to address unmet medical needs.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, UNITED STATES, 10591-6707
Fiscal year end:
December
Market capitalization:
$63.6 Billion
EBITDA:
$4.47 Billion
PERatio:
15.13
EPS:
39.66
Dividend per share:
$1.76
Dividend yield:
0.29%
Beta:
0.307

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+21%
How much will you get:
$1,214
Prices dates:
30-09-2015: $463.18 and 30-09-2025: $562.27